Startup Expedition Medicines Launches to Learn Nature’s Rules for Binding Elusive Proteins
Thousands of proteins are known to cause disease, but while the biological activity of these proteins is understood, the way to hit and modulate them with a drug is not. Nature still has ways to bind molecules to these elusive proteins, said Molly Gibson, co-founder and CEO of startup Expedition Medicines. What scientists have lacked…